Methotrexate

NDC 61703-350 · Hospira, Inc.

FDA carries 2 listing records for this NDC; the most recent is shown.

Generic nameMethotrexate

Dosage formINJECTION, SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)METHOTREXATE SODIUM

Strength25 mg/mL

Pharmacologic classFolate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]

Marketing categoryNDA

Packages

61703-350-10 — 5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-10) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-09)

61703-350-38 — 5 VIAL, MULTI-DOSE in 1 CARTON (61703-350-38) / 2 mL in 1 VIAL, MULTI-DOSE (61703-350-37)

J9260 — Injection, methotrexate sodium, 50 mg Medicare Part B payment limit (ASP + 6%): $2.94

FDA lists these products with the same active ingredient.

59137-515 — methotrexate, 59137-520 — methotrexate, 59137-525 — methotrexate, 59137-530 — methotrexate, 59137-535 — methotrexate, 59137-540 — methotrexate, 59137-550 — methotrexate, 59651-182 — Methotrexate, 61703-124 — Methotrexate, 61703-161 — Methotrexate, 61703-408 — Methotrexate, 62135-772 — Methotrexate, 62332-711 — methotrexate, 62332-712 — methotrexate, 62332-730 — METHOTREXATE, 63323-122 — METHOTREXATE SODIUM, 63323-123 — METHOTREXATE SODIUM, 64850-330 — Methotrexate Sodium, 67046-1524 — Methotrexate, 68071-3765 — Methotrexate, +34 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.